Related Experiment Video
Updated: Jan 1, 2026

Electrocardiogram Recordings in Anesthetized Mice using Lead II
Published on: June 20, 2020
Acquired long QT syndrome in chronic kidney disease patients
Peng Liu1, Lu Wang1,2, Dan Han1
1Department of Cardiovascular Medicine, First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, P.R. China.
Insights
Acquired long QT syndrome (aLQTS) is common in chronic kidney disease (CKD) patients, increasing sudden cardiac death risk. This review covers aLQTS in CKD, focusing on management strategies.
Area of Science:
- Nephrology
- Cardiology
- Clinical Medicine
Background:
- Cardiovascular disease (CVD) is the primary cause of death in chronic kidney disease (CKD) patients.
- QT interval prolongation, particularly acquired long QT syndrome (aLQTS), is linked to increased risks of torsade de pointes (TdP), sudden cardiac death (SCD), and mortality.
- CKD patients exhibit a high prevalence of aLQTS, with prolonged QT intervals serving as an independent risk factor for SCD and overall mortality.
Purpose of the Study:
- To review the epidemiological characteristics, risk factors, and mechanisms of aLQTS in CKD patients.
- To discuss current and potential treatment strategies for aLQTS in the context of CKD.
- To enhance the clinical management of aLQTS among individuals with CKD.
Main Methods:
- Literature review focusing on studies investigating QT interval prolongation and aLQTS in CKD.
- Analysis of epidemiological data, identified risk factors, and proposed pathophysiological mechanisms.
- Synthesis of information on therapeutic interventions for aLQTS in CKD patients.
Main Results:
- CKD is associated with a high prevalence of aLQTS.
- Prolonged QT interval in CKD is a significant independent risk factor for SCD and all-cause mortality.
- Various acquired conditions contribute to QT prolongation in CKD patients.
Conclusions:
- Effective management of aLQTS is crucial for improving outcomes in CKD patients.
- Further research into the specific mechanisms and targeted treatments for aLQTS in CKD is warranted.
- Addressing aLQTS in CKD can mitigate cardiovascular risks and reduce mortality.
Abstract:
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in chronic kidney disease (CKD) patients. QT interval prolongation is a congenital or acquired condition that is associated with an increased risk of torsade de pointes (TdP), sudden cardiac death (SCD), and all-cause mortality in the general population. The prevalence of acquired long QT syndrome (aLQTS) is high, and various acquired conditions contribute to the prolonged QT interval in patients with CKD. More notably, the prolonged QT interval in CKD is an independent risk factor for SCD and all-cause mortality. In this review, we focus on the epidemiological characteristics, risk factors, underlying mechanisms and treatments of aLQTS in CKD, promoting the management of aLQTS in CKD patients.
More Related Videos
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction
Acute Kidney Injury III: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care

